Patient With Progression After Taxanes

Drug	Drug Name	Drug Description
DB01101	Capecitabine	A nucleoside metabolic inhibitor indicated to treat different gastrointestinal, including pancreatic cancer, and breast cancer.

Drug	Drug Name	Target	Type
DB01101	Capecitabine	Thymidylate synthase	target
DB01101	Capecitabine	Thymidine phosphorylase	enzyme
DB01101	Capecitabine	Cytidine deaminase	enzyme
DB01101	Capecitabine	Liver carboxylesterase 1	enzyme
DB01101	Capecitabine	Cytochrome P450 2C9	enzyme
DB01101	Capecitabine	DNA	target
DB01101	Capecitabine	RNA	target
DB01101	Capecitabine	Serum albumin	carrier
DB01101	Capecitabine	Uridine phosphorylase 1	enzyme
DB01101	Capecitabine	Uridine phosphorylase 2	enzyme

Drug	Drug Name	Phase	Status	Count
DB01101	Capecitabine	2	Completed	1
DB00441	Gemcitabine	2	Completed	1
DB01259	Lapatinib	2	Completed	1
DB00361	Vinorelbine	2	Completed	1